$LLY · ELI LILLY & Co SEC Filings
Position Tracker tracks 10 SEC EDGAR filings for ELI LILLY & Co ($LLY) from October 8, 2026 through October 29, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 6 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$LLY 10-Q — ELI LILLY & Co
Lilly's 39% revenue growth and 50% nine-month net income surge confirm the GLP-1 franchise is still accelerating, but the $4.2B quarterly IPR&D spend raises the stakes on pipeli…
$LLY 8-K — ELI LILLY & Co
A $5.5B guidance raise from a $1.2T+ market-cap company is an exceptionally large absolute revision, confirming the GLP-1 franchise still has significant runway.
$LLY 3 — Eli Lilly and Company
Eli Lilly and Company filed a Form 3 with the SEC on October 22, 2026, reporting an initial ownership position in Lycia Therapeutics, Inc. (LYCA). The filing states that Eli Lil…
$LLY 4 — Eli Lilly and Company
Eli Lilly and Company filed a Form 4 with the SEC on October 20, 2026, reporting a change in beneficial ownership for director Gabrielle Sulzberger. The filing states that on Oc…
$LLY 4 — Eli Lilly and Company
This Form 4 filing reports a change in beneficial ownership by Juan R. Luciano, a director of Eli Lilly and Company. On October 19, 2026, Luciano acquired 12.8325 shares of Eli…
$LLY 4 — Eli Lilly and Company
This Form 4 filing reports a change in beneficial ownership for J. Erik Fyrwald, a director of Eli Lilly and Company. On October 19, 2026, Fyrwald acquired 7.9951 shares of Eli…
$LLY 4 — Eli Lilly and Company
On October 19, 2026, Ralph Alvarez, a director of Eli Lilly and Company, reported an acquisition of common stock in a Form 4 filing with the SEC. The filing states that he acqui…
$LLY SC 13G/A — Eli Lilly and Company
This filing is an amended Schedule 13G submitted by Lilly Endowment, Inc., an Indiana nonprofit private foundation, concerning its ownership of Eli Lilly and Company common stoc…
$LLY SC 13D — Eli Lilly and Company
Eli Lilly and Company filed a Schedule 13D with the SEC regarding its ownership of common stock in TRex Bio, Inc. The filing reports that Lilly beneficially owns 5,480,872 share…
$LLY 3 — Eli Lilly and Company
Eli Lilly and Company filed a Form 3 with the Securities and Exchange Commission on October 8, 2026, reporting an initial beneficial ownership position in TRex Bio, Inc., which…